: Online Library

Dear participant of the ISOBM 2010 meeting,
please have a look at our online library, where some oral presentations and posters are provided.
For the PDF-file please click on the title below.

Oral Presentations:

Saturday 4. September 2010
Lunch Symposium: Fujirebio Diagnostics		M Olsson - Fujirebio Diagnostics AB, Sweden "Clinical Relevance of Analyte Levels and Appropriate Matrix Composition for Commercial Tumor Marker Multi Constituent Controls"
Lunch Symposium: Siemens Healthcare Diagnostics		R Molina - Barcelona, Spain "How Can I better Support Oncologists with Results from my Laboratory?"
Free Communications: Biomarkers in Basic Oncology		A Carpi, A Nicolini - Pisa, Italy "Methological and Clinical Progress in Thyroid Tumor Markers"
Free Communications: Biomarkers in Breast Cancer		Elena Gershtein, A Platova, A Scherbakov, G Tchemeris, N Kushlinsky - Moscow, Russia "Comparative Elisa Study of Nf-Kappb P65 and P50, its Inhibitor Ikappab, and Upstream Effector Protein Kinase Akt1 Expression and Activity in the Tumors of Breast Cancer Patients" J Neugebauer, U Andergassen, C Schindelbeck, A Schneeweiss, T Zwingers, W Lichtenegger, MW Beckmann, K Friese, W Janni, B Rack - Munich, Germany "The Prognostic Relevance of Serum CA27.29 Level in Primary Breast Cancer Patients before Adjuvant Chemotherapy - Results of the German Success Trial" Nina Ditsch, B Toth, Miriam Lenhard, K Friese, Doris Mayr, U Schenke - Munich, Germany "Thyroid Hormone Receptor (TR) Expression in Malignent Breast Tumors" A Nicolini, P Ferrari, S Fancelli, M Collareta, M Conte, L Anselmi, P Berti, P Miccoli - Pisa, Italy "Specificity of an Individual Reference Limit (IRL) Compared with Conventional Cut-off during Intensive Post-operative Monitoring of Disease-free Breast Cancer Patients with serum CEA-TPA-CA15.3 Tumor Marker Panel"
Sunday 5. September 2010
Lunch Symposium: Abbott Diagnostics		R Molina - Barcelona, Spain "Multicentric evaluation of Tumor Markers in patients with suspicious signs of lung cancer."
Free Communications: Predictive Biomarkers		Stefanie Froehner, A Roesler, R Büttner - Penzberg, Germany "Verification of Biomarker Geneexpression Assays for Predictive Diagnostics within the HER2/EGFR Pathway" R Buettner, R Rashid, R Corzano, M Senthil, J Lin, M Hedvat, A Schroeder, A Mao, A Herrmann, J Yim, H Li, Y-C Yuan, K Yakushijin, N Vaidehi, G Gugiu, T-D Lee, R Yip, Y Chen, R Jove, D Horne, J-C Williams - LA, USA "Alkylation of Cysteine 468 in Stat3 Defines a Novel Site for Therapeutic Developement" Antje Kretschmar, R Tetzner, M Ebert - Munich, Germany "Detection of Colorectal Adenomas in Blood Using DNA Methylation Biomarkers" S Monnier-Benoit, Laura Ciarloni, S Hosseinian, N Imaizumi, S Therianos, L Wieczorek, C Nichita, G Dorta, C Rüegg - Lausanne, Switzerland "Two Signatures for a New Blood-Based Test for Colorectal Cancer Screening"
Monday 6. September 2010
Free Communications: Biomarkers in Ovarian Cancer		WC Hitt, PJ Stone, RA Dennis, MJ Cannon, K O'Brien, D Rose, K Shigemasa, JB Beard, TJ O'Brien - Little Rock, USA "New Biomarkers Help Monitor Patients Deficient in CA125 and Move Diagnosis from Late Stage toward Stage I and II" JM Escudero, JM Auge, X Filella, L Foj, R Molina - Barcelona, Spain "The Utility of HE4, CA125 in the Diagnosis of Ovarian Cancer"
Tuesday 7. September 2010
TD Workshop: HCG		Elisabeth Paus, K Nustad - Oslo, Norway "Immunoassays for Free hCGß"
Free Communications: Biomarkers in Urological Cancers		A Schrattenholz, GP Schwall, K Groebe - Mainz, Germany "The Challenge of Protein Biomarkers: Finding the needle in the haystick and validating it; Annexin A3 in prostate cancer" U Deligezer, F Yaman, E Darendeliler, Y Dizdar, S Holdenrieder, M Kovancilar, N Dalay - Istanbul, Turkey "Circulating Plasma BMP6 mRNA, Cell-free DNA, Nucleosomes and H3K27 Methylation in Prostate Cancer" JS Blanchet, S Vincendeau, X Durand, JN Ramirez, K Bensalah, B Guille, A Houlgatte - Nyon, Switzerland "Detection of Aggressive Prostate Cancer Using [-2]proPSA and the Prostate Health Index" Dina Nikulina, Y Kriventcev, R Bisalieva, L Zakljakova, N Borisova - Astrakhan, Russia "Embryonic and Fetal Hemoglobins Are Not Only Indicators of Hypoxia, But Also Possibly Additional Markers in Monitoring Patients with Hemoblastosis"
Bio-Statistics Workshop		C Miller, B Schwalb, K Maier, D Schulz, S Dümke, B Zacher, A Mayer, J Sydow, L Marcinowski, L Doelken, D Martin, A Tresch, P Cramer - Munich, Germany "The Dinamics of MRNA Synthesis and Decay During the Osmotic Stress Response in Yeast"

Poster Presentations:


X Filella, J Alcover, R Molina, JM Auge, J Corral, JM Escudero - Barcelona Spain		*Prognostic Value of the Percentage of free PSA in the Localized Prostate Cancer*
Elena Gershtein, D Kushlinsky, N Levkina, K Laktionov, L Adamyan - Moscow, Russia		*Vascular Endothelial Growth Factor and its Receptors in Tumor Tissue and Blood Serum of Patients with Ovarian Neoplasms: Clinico-Pathologic Analysis*
Maria Glas, F Spelsberg, Dorothea Nagel, Katja Krocker, Karin Hofmann, R Hatz, Petra Stieber - Munich, Germany		*Diagnostic Capacity of Cytokeratin 19 Fragments (CYFRA 21-1) in Lung Cancer: Comparison of the Immunoasays on the Architect System (Abbott Diagnostics) and the Elecsys System (Roche Diagnostics)*
J Tcherkassova, N Lyubimova, R Schmid, R Moro - Richmond, Canada		*Serum RECAF Decreases after Surgery in Patients with Early Stages of Breast Cancer*
A Vasko, B Acon, B Burkhart, C Glover, L Zhu, A Kahney, Katja Krocker, Karin Hofmann, Z Li, Petra Stieber, T Kettlety, O Nilsson - Göteborg, Sweden		*Analytical Performance of an Architect Assay for Measurement of Circulating CYFRA 21-1*
T Kettlety, R Radwan, A Vasko, B Burkhart, C Glover, L Zhu, B Acon, J Young, J Polkowski, K Falcone, S Raju, Z Li, D Dickson, R Simamora, G Barnes, O Nilsson - Göteborg, Sweden		*Performance of Architect HE4 in Monitoring Patients with Epithelial Ovarian Cancer and Estimating Risk of Epithelial Ovarian Cancer in Woman with an Adnexal Mass*
Sabah Abdel-Hady, H Elaggan, S Hegab, WA El-Delgawi, N El Deeb, R Shams - Alexandria, Egypt		*Activin A /Follistatin and Mage-1 and Mage-3 Gene Transcripts: Markers of Hepatocellular Carcinoma*
V Sologub, I Koromyslova, S Severin - Moscow, Russia		*Monoclonal Antibodies Cross-Reactive with Thyroglobulin (TG) and Thyroid Peroxidase (TPO). Possibility to Apply them for Detection of Antigenes in Human Samples*
Shaymaa MM Yahya - Cairo, Egypt		*RNA Interference (RNAi) as a Promising Gene Therapy for Hepatocellular Carcinoma*
Hanaa M Rady, Shaymaa MM Yahya - Cairo Egypt		*Enhancement of Antitumor Effect of Honey using Adiponectin Hormone*
Linda Hertlein, A Burges, M Lenhard, A Kirschenhofer, S Fürst, D Mayer, D Nagel, K Hofmann, K Krocker, P Stieber - Munich, Germany		HE4 in Benign and Malignant Diseases
Catrin Middleton, W Irving, JFR Robertson, A Murrray, P Maddison, BJ Thomson, CJ Chapman - Nottingham, UK		Does Heat Treatment of Human Serum Affect the Measurement of Autoantibodies to Recombinant Tumor-Associated Antigens?
PM Hemken, K Morota, M Nakagawa, R Sekiya, LJ Sokoll, DJ Elliot, BL Dowell - Abbott Diagnostics, USA		*Performance Comparison of GP73, Fucosylated Hemopexin, PIVKA-li and AFP in a Cohort of Liver Disease Specimens*
J Kotyza, Karin Bunatova, D Havel, J Vrzalova, M Pesek - Plzen, Czech Republic		*Lung Tumor - Associated Pleural Fluids: Diagnostic and Prognostic Value of Inflammatory Markers*
JM Auge, F Macia, J Grau, A Buron, A Serradesanferm, M Andreu, M Pellise, C Hernandez, A Castells, R Molina - Barcelona, Spain		*Utility of the Immunochemical Faecal Occult Blood Tests to Detect Significant Colorectal Neoplasia*
JM Auge, F Macia, J Grau, A Buron, A Serradesanferm, A Andreu, M Pellise, C Hernandez, A Castells, R Molina - Barcelona, Spain		*The Catalan Colorectal Cancer Screening Programme. The Role of the Laboratory*
JS Blanchet, X Durand, A Houlgatte, JN Ramirez, K Bensalah, B Guille, S Vincendeau - Nyon Switzerland		*The Beckman Coulter Prostate Health Index (Phi) Increases the Specificity of Detection of Prostate Cancer and Reduces the Number of Negative Biopsies*
JS Blanchet, A Houlgatte, X Durand, JN Ramirez, K Bensalah, B Guille, S Vincendeau - Nyon, Switzerland		*The Isoform [-2] Propsa and thr Prostate Health Index (Phi) Improve the Detection of Prostate Cancer for Patients with Total PSA between 1.8 and 8.0 ng/ml*